MyoStrain

05/10/2026

This Mother’s Day, we recognize and celebrate the mothers, caregivers, physicians, researchers, and leaders who dedicate themselves to caring for others both at home and throughout the healthcare community.

Thank you for the compassion, resilience, and impact you bring each day. Wishing you a happy and meaningful Mother’s Day from all of us at Myocardial Solutions.

04/30/2026

Real stories like this highlight the importance of monitoring heart health throughout cancer treatment.

After experiencing a significant drop in cardiac function during chemotherapy, this patient was able to track recovery over time through continued MyoStrain and MyoStress imaging. With the right care plan in place, their heart health improved and remained stable.

Having visibility into these changes can make a meaningful difference in how patients are supported during and after treatment.
Learn more about how MyoStrain is used in cardio-oncology:https://bit.ly/4aTU71T

04/28/2026

Did you know that 1 in 4 people who suffer a heart attack show none of the traditional warning signs?

A groundbreaking article in Scientific American highlights how chronic inflammation — not just high cholesterol — may be quietly driving heart disease for millions of people.

That's why early, precise cardiac assessment matters more than ever. MyoStrain by Myocardial Solutions uses advanced cardiac MRI analysis to detect subtle changes in heart function — giving your care team the information they need, sooner.

Because the best time to catch a heart problem is before it becomes one.

Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down

04/24/2026

Cardiac imaging is evolving, and so is how we interpret it.

With MyoStrain 6.1, more comprehensive reporting brings together timing parameters, RV MyoHealth, 3D visualization, and automated insights into one streamlined view. Clinically relevant thresholds and changes are highlighted automatically, making interpretation clearer and more efficient.

Because in many cases, it is not just about how strong the heart contracts, but how well it works together.
Learn more about the latest updates: https://bit.ly/4aTU71T

04/17/2026

Hearing directly from clinicians using MyoStrain in practice is what matters most.

Dr. Kathryn A. Gayle highlights how the updated software is helping her team confidently monitor oncology patients while also supporting newer technicians as they build expertise in cardiac MRI.
When technology is both precise and practical, it can make a real difference in day-to-day care.

Learn more about how MyoStrain is supporting clinical teams: https://bit.ly/4aTU71T

04/17/2026

Hearing directly from clinicians using MyoStrain in practice is what matters most.
Dr. Kathryn A. Gayle highlights how the updated software is helping her team confidently monitor oncology patients while also supporting newer technicians as they build expertise in cardiac MRI.
When technology is both precise and practical, it can make a real difference in day-to-day care.
Learn more about how MyoStrain is supporting clinical team. Link in bio.

03/30/2026

As part of the MyoStrain® 6.1 release, functional assessment now goes beyond strain magnitude alone. By incorporating temporal and mechanical efficiency parameters, clinicians can now assess how well the myocardium coordinates and transitions throughout the cardiac cycle.
Available when semi-automatic contouring is completed, these new parameters evaluate mechanical coordination, temporal synchrony, and myocardial elasticity, including the transition from systole to diastole.
Importantly, these metrics can help identify subclinical dysfunction even when strain values and LVEF remain preserved, supporting earlier and more comprehensive assessment.

03/27/2026

MyoStrain® and the MyoHealth Score enable physicians to classify and risk-stratify asymptomatic cardiac patients in alignment with ACC/AHA standardized heart failure stages.
By establishing a MyoHealth baseline, clinicians gain a longitudinal view of myocardial function. Each score can be plotted along a progressive dysfunction curve, helping quantify how cardiac health changes over time.
This approach supports earlier identification of dysfunction and allows physicians to individualize treatment strategies based on patient response, with the ability to monitor the heart long-term.

03/27/2026

MyoStrain® and the MyoHealth Score enable physicians to classify and risk-stratify asymptomatic cardiac patients in alignment with ACC/AHA standardized heart failure stages.
By establishing a MyoHealth baseline, clinicians gain a longitudinal view of myocardial function. Each score can be plotted along a progressive dysfunction curve, helping quantify how cardiac health changes over time.
This approach supports earlier identification of dysfunction and allows physicians to individualize treatment strategies based on patient response, with the ability to monitor the heart long-term.
Read the published research: https://bit.ly/4s34QgL

03/16/2026

Listening to clinicians drives innovation.
Based on feedback from physicians, MyoStrain® 6.1 includes improved LVEF quantification within the MyoStrain report, enhancing volumetric assessment as part of a comprehensive non-contrast CMR evaluation.
These updates support the ongoing monitoring of cardio-oncology and cardiac patients with greater clarity and confidence.